In a new article published in Chain Drug Review, Frier Levitt partner Harini Bupathi examines common PBM audit issues observed in 2025 and outlines key steps pharmacies should consider as they prepare for 2026.
The article, “2025 PBM Audit Insights: What Pharmacies Need to Know Heading Into 2026,” highlights recurring challenges such as inventory shortages and the use of third-party services, which continue to trigger heightened PBM scrutiny. Harini notes that as audits grow more complex and frequent, pharmacies cannot rely on reactive strategies alone. Instead, they must focus on strengthening documentation practices, maintaining strict contract adherence, and implementing proactive compliance measures.
By staying ahead of these issues, pharmacies can not only reduce exposure to costly audits but also protect their long-term business stability.
Read the full article here: https://chaindrugreview.com/2025-pbm-audit-insights-what-pharmacies-need-to-know-heading-into-2026/
